Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback